Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-043993
Filing Date
2022-08-02
Accepted
2022-08-02 19:08:46
Documents
2
Period of Report
2022-08-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1526
2 POA DOCUMENT poa.txt EX-24 3030
  Complete submission text file 0001209191-22-043993.txt   5920
Mailing Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612
Business Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612 (858) 283-0280
Reneo Pharmaceuticals, Inc. (Issuer) CIK: 0001637715 (see all company filings)

EIN.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11682 EL CAMINO REAL STE 300 SAN DIEGO CA 92130
Business Address
Blunt Roshawn A. (Reporting) CIK: 0001787773 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40315 | Film No.: 221130489